Close Menu

NEW YORK — JP Morgan and Piper Sandler on Monday initiated coverage of Ortho Clinical Diagnostics with Overweight ratings. JP Morgan initiated coverage with a share price target of $25, while Piper Sandler initiated coverage at $27. 

Further, Evercore ISI initiated coverage at $26 with an Outperform rating, and UBS initiated coverage at $23 with a Buy rating.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.